Carisma Therapeutics, Inc. (CARM) — Analyst estimates
Consensus analyst estimates for Carisma Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 9.11M | -0.52 | 1 |
| 2027 | 43.22M | -0.44 | 1 |
| 2028 | 9.98M | -0.42 | 1 |
| 2029 | 73.14M | -0.42 | 1 |
Consensus analyst estimates by fiscal year.